Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.01.2023 | Case report

Antithrombotics/tozinameran

Catastrophic antiphospholipid syndrome and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Jinno S, et al. Catastrophic antiphospholipid syndrome complicated with essential thrombocythaemia after COVID-19 vaccination: in search of the underlying mechanism. Rheumatology Advances in Practice 5: No. 3, Jan 2021. Available from: URL: http://doi.org/10.1093/rap/rkab096 Jinno S, et al. Catastrophic antiphospholipid syndrome complicated with essential thrombocythaemia after COVID-19 vaccination: in search of the underlying mechanism. Rheumatology Advances in Practice 5: No. 3, Jan 2021. Available from: URL: http://​doi.​org/​10.​1093/​rap/​rkab096
Metadaten
Titel
Antithrombotics/tozinameran
Catastrophic antiphospholipid syndrome and lack of efficacy: case report
Publikationsdatum
01.01.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-30349-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Propranolol

Case report

Sirolimus

Case report

Multiple drugs